PROPLEX vs. PROPLEX SX: a controlled double blind study of the effectiveness in treating acute hemarthroses in hemophilia A patients with inhibitors to factor VIII.
A blinded randomized multicenter trial of two non-activated prothrombin complex concentrates was carried out to determine the clinical effectivity in the treatment of acute hemarthrosis in hemophiliac patients with inhibitors. The one product was prepared via DEAE Sephadex chromatography, while the second was fractionated via various precipitation procedures including polyethylene glycol. Equivalence of the two products was established with less than 15% difference in efficacy rates.
D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D004311:Double-Blind Method; D005164:Factor IX / Q000008:administration & dosage*; D006395:Hemarthrosis / Q000188:drug therapy*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans
D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D005164:Factor IX